江龍船艇(300589.SZ):2022年員工持股計劃出售完畢
格隆匯7月11日丨江龍船艇(300589.SZ)公佈,截至2025年7月11日,公司2022年員工持股計劃所持有的4,348,581股公司股票已通過二級市場集中競價方式全部出售完畢,佔當前公司總股本的1.15%。公司實施2022年員工持股計劃期間,嚴格遵守市場交易規則,遵守中國證監會、深圳證券交易所關於信息敏感期不得買賣股票的規定,未利用內幕信息進行交易。根據相關法律法規以及公司《2022年員工持股計劃(草案修訂稿)》的相關規定,公司2022年員工持股計劃實施完畢並終止,後續將在終止日後30個工作日內完成相關資產的清算,並按持有人持有的份額比例進行分配。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.